ArticleQuantitative imaging in medicine and surgery2025
Evaluation of the stability of deep vein thrombosis based on computed tomography energy spectrum.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The stability of deep vein thrombosis (DVT) is currently a hotspot and difficult point of research for scholars in various countries. This study aimed to explore the feasibility of predicting the stability of DVT based on energy spectrum computed tomography (CT). The primary objective is to determine whether energy spectrum CT parameters can predict DVT stability. The secondary objective is to evaluate the predictive value of individual/combined parameters of spectral CT for acute pulmonary embolism (APE) risk. Methods: Patients who underwent lower limb energy spectrum CT and were diagnosed with DVT and underwent computed tomography pulmonary angiography (CTPA) at the First Affiliated Hospital of Hebei North University from October 2023 to November 2024 were consecutively enrolled in this study. Overall, 63 patients with DVT were included and categorized into DVT combined with APE group (n=40) and DVT without APE group (n=23). The quantitative energy spectrum CT parameters were compared between the two groups, including 40 keV CT value, the slope of the energy spectrum curve (λ), effective atomic number (Eff-Z), concentrations of calcium-water [Ca(W)], water-calcium [W(Ca)], iodine-water [I(W)], water-iodine [W(I)], calcium-iodine [Ca(I)], and iodine-calcium [I(Ca)]. Results: The 40 keV CT value, λ, Eff-Z, and I(W) value were statistically different between the two groups (P<0.05). The 40 keV CT value, λ, Eff-Z, and I(W) value were independent predictors of combined APE in patients with DVT. The area under the curve of 40 keV CT value, λ, Eff-Z, and I(W) values for predicting the risk of APE in patients with DVT were 0.791 [95% confidence interval (CI): 0.681-0.901], 0.726 (95% CI: 0.592-0.860), 0.745 (95% CI: 0.620-0.869), and 0.739 (95% CI: 0.617-0.860), respectively, and the combined curve was 0.930 (95% CI: 0.868-0.992). The calibration curves showed that the combined curve of the energy spectrum CT parameters was better in predicting the risk of APE in patients with DVT. The decision curve showed that the combined curve of energy spectrum CT parameters had a high clinical application value. Conclusions: The quantitative parameters of 40 keV CT value, λ, Eff-Z, and I(W) value derived on energy spectrum CT can be used as independent predictors of the risk of APE in patients with DVT, and the combined use of the energy spectrum parameters had valuable predictive performance for the risk of APE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.